| Gina Fosnot, | |
|
217 Boston Ave, Altamonte Springs, FL 32701-4700 | |
| (407) 260-0817 | |
| (407) 260-0817 |
| Full Name | Gina Fosnot |
|---|---|
| Gender | Female |
| Speciality | Qualified Speech Language Pathologist |
| Experience | 17 Years |
| Location | 217 Boston Ave, Altamonte Springs, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932342144 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SA 9708 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Next Pt Group Florida, Llc | 3173865607 | 32 |
News Archive
Long-term methadone treatment can cause changes in the brain, according to recent studies from the Norwegian Institute of Public Health. The results show that treatment may affect the nerve cells in the brain. The studies follow on from previous studies where methadone was seen to affect cognitive functioning, such as learning and memory.
Peggy Evans, PhD, CPHIT, Director of the Washington & Idaho Regional Extension Center testified before the House Committee on Energy and Commerce, Subcommittee of Health, Tuesday, July 27, 2010, in Washington, DC. Dr. Evans joined David Blumenthal, MD, National Coordinator for Health Information Technology and several others on two panels of witnesses.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced an amendment to its 2005 collaboration agreement with AstraZeneca expanding the TC-5619 development program. In addition to the current development of TC-5619 in cognitive dysfunction in schizophrenia (CDS), the amended terms provide for parallel development in attention deficit/hyperactivity disorder (ADHD) and potentially Alzheimer's disease.
The researchers said their findings could aid in development of treatments for cannabinoid drug abuse. Also, because so-called "endocannabinoids" produced by brain cells are involved in the neural machinery of pain perception and learning and memory, the findings could help in understanding those processes, said the researchers.
› Verified 8 days ago
| Provider Name | Next Pt Group Florida, Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1730666355 PECOS PAC ID: 3173865607 Enrollment ID: O20190501002988 |
News Archive
Long-term methadone treatment can cause changes in the brain, according to recent studies from the Norwegian Institute of Public Health. The results show that treatment may affect the nerve cells in the brain. The studies follow on from previous studies where methadone was seen to affect cognitive functioning, such as learning and memory.
Peggy Evans, PhD, CPHIT, Director of the Washington & Idaho Regional Extension Center testified before the House Committee on Energy and Commerce, Subcommittee of Health, Tuesday, July 27, 2010, in Washington, DC. Dr. Evans joined David Blumenthal, MD, National Coordinator for Health Information Technology and several others on two panels of witnesses.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced an amendment to its 2005 collaboration agreement with AstraZeneca expanding the TC-5619 development program. In addition to the current development of TC-5619 in cognitive dysfunction in schizophrenia (CDS), the amended terms provide for parallel development in attention deficit/hyperactivity disorder (ADHD) and potentially Alzheimer's disease.
The researchers said their findings could aid in development of treatments for cannabinoid drug abuse. Also, because so-called "endocannabinoids" produced by brain cells are involved in the neural machinery of pain perception and learning and memory, the findings could help in understanding those processes, said the researchers.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gina Fosnot, 9741 Lingwood Trl, Orlando, FL 32817-1881 Ph: (407) 678-3349 | Gina Fosnot, 217 Boston Ave, Altamonte Springs, FL 32701-4700 Ph: (407) 260-0817 |
News Archive
Long-term methadone treatment can cause changes in the brain, according to recent studies from the Norwegian Institute of Public Health. The results show that treatment may affect the nerve cells in the brain. The studies follow on from previous studies where methadone was seen to affect cognitive functioning, such as learning and memory.
Peggy Evans, PhD, CPHIT, Director of the Washington & Idaho Regional Extension Center testified before the House Committee on Energy and Commerce, Subcommittee of Health, Tuesday, July 27, 2010, in Washington, DC. Dr. Evans joined David Blumenthal, MD, National Coordinator for Health Information Technology and several others on two panels of witnesses.
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced an amendment to its 2005 collaboration agreement with AstraZeneca expanding the TC-5619 development program. In addition to the current development of TC-5619 in cognitive dysfunction in schizophrenia (CDS), the amended terms provide for parallel development in attention deficit/hyperactivity disorder (ADHD) and potentially Alzheimer's disease.
The researchers said their findings could aid in development of treatments for cannabinoid drug abuse. Also, because so-called "endocannabinoids" produced by brain cells are involved in the neural machinery of pain perception and learning and memory, the findings could help in understanding those processes, said the researchers.
› Verified 8 days ago
Emily Ellen Dykstra, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1146 Woodland Terrace Trl, Altamonte Springs, FL 32714 Phone: 407-928-5378 Fax: 407-522-8293 | |
Zachary Richard Grunberg, MSCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 238 N Westmonte Dr, Suite 200, Altamonte Springs, FL 32714 Phone: 800-226-9917 Fax: 800-224-6215 | |
Mrs. Brittany N Monroy, M.C.D. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 903 Red Bird Ln, Altamonte Springs, FL 32701 Phone: 813-728-5664 | |
Elana Wartell, MA/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 932 Poplar Dr, Altamonte Springs, FL 32714 Phone: 407-788-0953 Fax: 407-788-0953 | |
Communicare Therapies Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1251 W Forest Lake Dr, Altamonte Springs, FL 32714 Phone: 407-346-6530 | |
Ms. Adrian Leigh Patascher, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 217 Boston Ave, Altamonte Springs, FL 32701 Phone: 407-260-0817 | |
Ms. June Carol Bilotta, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 477 Oak Haven Dr, Altamonte Springs, FL 32701 Phone: 407-332-9353 |